Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Posterior cerebral artery reconstruction by in-situ bypass with the superior cerebellar artery via an occipital transtentorial approach.

Tanahashi K, Araki Y, Uda K, Muraoka S, Motomura K, Lushun C, Wakabayashi T, Natsume A.

World Neurosurg. 2019 Mar 4. pii: S1878-8750(19)30550-9. doi: 10.1016/j.wneu.2019.02.127. [Epub ahead of print] No abstract available.

PMID:
30844533
2.

Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.

Matsumura N, Nobusawa S, Ito J, Kakita A, Suzuki H, Fujii Y, Fukuda M, Iwasaki M, Nakasato N, Tominaga T, Natsume A, Mikami Y, Shinojima N, Yamazaki T, Nakazato Y, Hirato J, Yokoo H.

J Neurooncol. 2019 Mar 1. doi: 10.1007/s11060-019-03138-7. [Epub ahead of print]

PMID:
30825062
3.

Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.

Ranjit M, Hirano M, Aoki K, Okuno Y, Ohka F, Yamamichi A, Kato A, Maeda S, Motomura K, Matsuo K, Enomoto A, Ino Y, Todo T, Takahashi M, Wakabayashi T, Kato T, Natsume A.

Cell Rep. 2019 Feb 26;26(9):2274-2281.e5. doi: 10.1016/j.celrep.2019.01.109.

4.

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.

Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M.

Neuro Oncol. 2018 Nov 30. doi: 10.1093/neuonc/noy200. [Epub ahead of print]

PMID:
30500939
5.

Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study.

Wee CW, Kim IH, Park CK, Kim JW, Dho YS, Ohka F, Aoki K, Motomura K, Natsume A, Kim N, Suh CO, Chang JH, Kim SH, Cho WK, Lim DH, Nam DH, Choi JW, Kim IA, Kim CY, Oh YT, Cho O, Chung WK, Kim SH, Kim E.

Radiother Oncol. 2018 Nov;129(2):347-351. doi: 10.1016/j.radonc.2018.09.001. Epub 2018 Sep 17.

PMID:
30236994
6.

Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells.

Murakami T, Nakazawa T, Natsume A, Nishimura F, Nakamura M, Matsuda R, Omoto K, Tanaka Y, Shida Y, Park YS, Motoyama Y, Nakagawa I, Yamada S, Tamura K, Takeshima Y, Takamura Y, Wakabayashi T, Nakase H.

Anticancer Res. 2018 Sep;38(9):5049-5056. doi: 10.21873/anticanres.12824.

PMID:
30194149
7.

Characterization of Intraoperative Motor Evoked Potential Monitoring for Surgery of the Pediatric Population with Brain Tumors.

Motomura K, Sumita K, Chalise L, Nishikawa T, Tanahashi K, Ohka F, Aoki K, Hirano M, Nakamura T, Matsushita T, Wakabayashi T, Natsume A.

World Neurosurg. 2018 Nov;119:e1052-e1059. doi: 10.1016/j.wneu.2018.08.039. Epub 2018 Aug 16.

PMID:
30121408
8.

Supratotal Resection of Diffuse Frontal Lower Grade Gliomas with Awake Brain Mapping, Preserving Motor, Language, and Neurocognitive Functions.

Motomura K, Chalise L, Ohka F, Aoki K, Tanahashi K, Hirano M, Nishikawa T, Wakabayashi T, Natsume A.

World Neurosurg. 2018 Nov;119:30-39. doi: 10.1016/j.wneu.2018.07.193. Epub 2018 Aug 1.

PMID:
30075269
9.

Inflammation Flare and Radiation Necrosis Around a Stereotactic Radiotherapy-Pretreated Brain Metastasis Site After Nivolumab Treatment.

Furuta H, Yoshida T, Natsume A, Hida T, Yatabe Y.

J Thorac Oncol. 2018 Dec;13(12):1975-1978. doi: 10.1016/j.jtho.2018.07.005. Epub 2018 Jul 12. No abstract available.

PMID:
30017830
10.

Cytokine Therapy of Gliomas.

Iwami K, Natsume A, Wakabayashi T.

Prog Neurol Surg. 2018;32:79-89. doi: 10.1159/000469682. Epub 2018 Jul 10. Review.

PMID:
29990976
11.

Pediatric-Type Follicular Lymphoma in the Dura: A Case Report and Literature Review.

Yamaguchi J, Kato S, Iwata E, Aoki K, Kabeya R, Natsume A, Wakabayashi T.

World Neurosurg. 2018 Jul;115:176-180. doi: 10.1016/j.wneu.2018.04.053. Epub 2018 Apr 17. Review.

PMID:
29678710
12.

Neuroendoscopic Cylinder Surgery and 5-Aminolevulinic Acid Photodynamic Diagnosis of Deep-Seated Intracranial Lesions.

Choo J, Takeuchi K, Nagata Y, Ohka F, Kishida Y, Watanabe T, Satoh Y, Nagatani T, Kato K, Wakabayashi T, Natsume A.

World Neurosurg. 2018 Aug;116:e35-e41. doi: 10.1016/j.wneu.2018.03.112. Epub 2018 Mar 23.

PMID:
29581022
13.

Podoplanin: An emerging cancer biomarker and therapeutic target.

Krishnan H, Rayes J, Miyashita T, Ishii G, Retzbach EP, Sheehan SA, Takemoto A, Chang YW, Yoneda K, Asai J, Jensen L, Chalise L, Natsume A, Goldberg GS.

Cancer Sci. 2018 May;109(5):1292-1299. doi: 10.1111/cas.13580. Review.

14.

JCOG0911 INTEGRA study: a randomized screening phase II trial of interferon╬▓ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG).

J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20.

15.

Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion.

Yamamichi A, Ohka F, Aoki K, Suzuki H, Kato A, Hirano M, Motomura K, Tanahashi K, Chalise L, Maeda S, Wakabayashi T, Kato Y, Natsume A.

Brain Tumor Pathol. 2018 Apr;35(2):106-113. doi: 10.1007/s10014-018-0312-5. Epub 2018 Mar 17.

PMID:
29550880
16.

A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR.

Hirano M, Ohka F, Maeda S, Chalise L, Yamamichi A, Aoki K, Kato A, Tanahashi K, Motomura K, Nishimura Y, Hara M, Shinjo K, Kondo Y, Wakabayashi T, Natsume A.

Brain Tumor Pathol. 2018 Apr;35(2):97-105. doi: 10.1007/s10014-018-0310-7. Epub 2018 Feb 19.

PMID:
29460200
17.

Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.

Komuro A, Raja E, Iwata C, Soda M, Isogaya K, Yuki K, Ino Y, Morikawa M, Todo T, Aburatani H, Suzuki H, Ranjit M, Natsume A, Mukasa A, Saito N, Okada H, Mano H, Miyazono K, Koinuma D.

Int J Cancer. 2018 Apr 15;142(8):1627-1639. doi: 10.1002/ijc.31179. Epub 2017 Dec 11.

PMID:
29193056
18.

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.

Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T, Nagata Y, Yoshizato T, Mizoguchi M, Abe T, Momii Y, Muragaki Y, Watanabe R, Ito I, Sanada M, Yajima H, Morita N, Takeuchi I, Miyano S, Wakabayashi T, Ogawa S, Natsume A.

Neuro Oncol. 2018 Jan 10;20(1):66-77. doi: 10.1093/neuonc/nox132.

19.

Remote ischemic preconditioning protects human neural stem cells from oxidative stress.

Motomura A, Shimizu M, Kato A, Motomura K, Yamamichi A, Koyama H, Ohka F, Nishikawa T, Nishimura Y, Hara M, Fukuda T, Bando Y, Nishimura T, Wakabayashi T, Natsume A.

Apoptosis. 2017 Nov;22(11):1353-1361. doi: 10.1007/s10495-017-1425-8.

PMID:
28951984
20.

Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.

Shiraki Y, Mii S, Enomoto A, Momota H, Han YP, Kato T, Ushida K, Kato A, Asai N, Murakumo Y, Aoki K, Suzuki H, Ohka F, Wakabayashi T, Todo T, Ogawa S, Natsume A, Takahashi M.

J Pathol. 2017 Dec;243(4):468-480. doi: 10.1002/path.4981. Epub 2017 Nov 1.

PMID:
28888050
21.
22.

Significance of low mTORC1 activity in defining the characteristics of brain tumor stem cells.

Han YP, Enomoto A, Shiraki Y, Wang SQ, Wang X, Toyokuni S, Asai N, Ushida K, Ara H, Ohka F, Wakabayashi T, Ma J, Natsume A, Takahashi M.

Neuro Oncol. 2017 May 1;19(5):636-647. doi: 10.1093/neuonc/now237.

23.

A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production.

Tanaka K, Natsume A, Ishikawa S, Takenaka S, Yoshida KI.

Microb Cell Fact. 2017 Apr 21;16(1):67. doi: 10.1186/s12934-017-0682-0.

24.

Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.

Deguchi S, Katsushima K, Hatanaka A, Shinjo K, Ohka F, Wakabayashi T, Zong H, Natsume A, Kondo Y.

Oncogene. 2017 Aug 10;36(32):4629-4640. doi: 10.1038/onc.2017.88. Epub 2017 Apr 3.

PMID:
28368417
25.

Synthesis of PET probe O6-[(3-[11C]methyl)benzyl]guanine by Pd0-mediated rapid C-[11C]methylation toward imaging DNA repair protein O6-methylguanine-DNA methyltransferase in glioblastoma.

Koyama H, Ikenuma H, Toda H, Kondo G, Hirano M, Kato M, Abe J, Yamada T, Wakabayashi T, Ito K, Natsume A, Suzuki M.

Bioorg Med Chem Lett. 2017 May 1;27(9):1892-1896. doi: 10.1016/j.bmcl.2017.03.045. Epub 2017 Mar 18.

PMID:
28363750
26.

A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma.

Ohka F, Yamamichi A, Kurimoto M, Motomura K, Tanahashi K, Suzuki H, Aoki K, Deguchi S, Chalise L, Hirano M, Kato A, Nishimura Y, Hara M, Kato Y, Wakabayashi T, Natsume A.

Brain Tumor Pathol. 2017 Apr;34(2):91-97. doi: 10.1007/s10014-017-0281-0. Epub 2017 Mar 28.

PMID:
28353033
27.

Girdin maintains the stemness of glioblastoma stem cells.

Natsume A, Kato T, Kinjo S, Enomoto A, Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, Miyata T, Takahashi M, Wakabayashi T.

Oncogene. 2017 Jun 29;36(26):3796. doi: 10.1038/onc.2017.17. Epub 2017 Feb 20.

PMID:
28218901
28.

Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan.

Takayanagi S, Mukasa A, Nakatomi H, Kanno H, Kuratsu JI, Nishikawa R, Mishima K, Natsume A, Wakabayashi T, Houkin K, Terasaka S, Yao M, Shinohara N, Shuin T, Saito N.

Neurol Med Chir (Tokyo). 2017 Feb 15;57(2):59-65. doi: 10.2176/nmc.ra.2016-0206. Epub 2017 Jan 6. Review.

29.

Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.

Motomura K, Natsume A, Iijima K, Kuramitsu S, Fujii M, Yamamoto T, Maesawa S, Sugiura J, Wakabayashi T.

J Neurosurg. 2017 Oct;127(4):790-797. doi: 10.3171/2016.9.JNS16152. Epub 2017 Jan 6.

PMID:
28059650
30.

Adoptive immunotherapy for the treatment of glioblastoma: progress and possibilities.

Kuramitsu S, Yamamichi A, Ohka F, Motomura K, Hara M, Natsume A.

Immunotherapy. 2016 Dec;8(12):1393-1404. doi: 10.2217/imt-2016-0076. Review.

PMID:
28000534
31.

Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment.

Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, Shibata T, Naito M, Kim HJ, Miyata K, Kataoka K, Kondo Y.

Nat Commun. 2016 Dec 6;7:13616. doi: 10.1038/ncomms13616.

32.

Dedifferentiated chordoid meningioma with rhabdomyosarcomatous differentiation on the middle cranial fossa.

Fudaba H, Abe T, Morishige M, Momii Y, Kashima K, Yamada A, Nagatomi H, Natsume A, Hirato J, Nakazato Y, Fujiki M.

Neuropathology. 2016 Dec;36(6):579-583. doi: 10.1111/neup.12310. Epub 2016 May 16.

PMID:
27910213
33.

Efficacy of the transtemporal approach with awake brain mapping to reach the dominant posteromedial temporal lesions.

Iijima K, Motomura K, Chalise L, Hirano M, Natsume A, Wakabayashi T.

Acta Neurochir (Wien). 2017 Jan;159(1):177-184. doi: 10.1007/s00701-016-3035-6. Epub 2016 Nov 25.

PMID:
27888341
34.

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas.

Yamamichi A, Kasama T, Ohka F, Suzuki H, Kato A, Motomura K, Hirano M, Ranjit M, Chalise L, Kurimoto M, Kondo G, Aoki K, Kaji N, Tokeshi M, Matsubara T, Senga T, Kaneko MK, Suzuki H, Hara M, Wakabayashi T, Baba Y, Kato Y, Natsume A.

Sci Technol Adv Mater. 2016 Oct 4;17(1):618-625. eCollection 2016.

35.

Bacillus subtilis 5'-nucleotidases with various functions and substrate specificities.

Terakawa A, Natsume A, Okada A, Nishihata S, Kuse J, Tanaka K, Takenaka S, Ishikawa S, Yoshida KI.

BMC Microbiol. 2016 Oct 26;16(1):249.

36.

[The mechanisms'of glioma formation: Insights into molecular mechanism and cell of origin].

Ohka F, Suzuki H, Aoki K, Natsume A.

Nihon Rinsho. 2016 Sep;74 Suppl 7:167-171. Japanese. No abstract available.

PMID:
30634749
37.

[CIC].

Suzuki H, Aoki K, Ohka F, Natsume A.

Nihon Rinsho. 2016 Sep;74 Suppl 7:143-147. Japanese. No abstract available.

PMID:
30634745
38.

[IDH1, IDH2].

Suzuki H, Aoki K, Ohka F, Natsume A.

Nihon Rinsho. 2016 Sep;74 Suppl 7:117-121. Japanese. No abstract available.

PMID:
30634740
39.

CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains.

Shiina S, Ohno M, Ohka F, Kuramitsu S, Yamamichi A, Kato A, Motomura K, Tanahashi K, Yamamoto T, Watanabe R, Ito I, Senga T, Hamaguchi M, Wakabayashi T, Kaneko MK, Kato Y, Chandramohan V, Bigner DD, Natsume A.

Cancer Immunol Res. 2016 Mar;4(3):259-68. doi: 10.1158/2326-6066.CIR-15-0060. Epub 2016 Jan 28.

40.

Efficacy of early carotid endarterectomy for vulnerable plaque in the common carotid artery.

Tanahashi K, Araki Y, Maruwaka M, Natsume A.

Acta Neurochir (Wien). 2016 Mar;158(3):561-3. doi: 10.1007/s00701-016-2706-7. Epub 2016 Jan 18. No abstract available.

PMID:
26780621
41.

Rapid sensitive analysis of IDH1 mutation in lower-grade gliomas by automated genetic typing involving a quenching probe.

Kurimoto M, Suzuki H, Aoki K, Ohka F, Kondo G, Motomura K, Iijima K, Yamamichi A, Ranjit M, Wakabayashi T, Kimura S, Natsume A.

Cancer Invest. 2016;34(1):12-5. doi: 10.3109/07357907.2015.1084001. Epub 2015 Dec 22.

PMID:
26695622
42.

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.

Kuramitsu S, Ohno M, Ohka F, Shiina S, Yamamichi A, Kato A, Tanahashi K, Motomura K, Kondo G, Kurimoto M, Senga T, Wakabayashi T, Natsume A.

Cancer Gene Ther. 2015 Oct;22(10):487-95. doi: 10.1038/cgt.2015.47. Epub 2015 Oct 9.

PMID:
26450624
43.

Antitumorigenic effect of interferon-╬▓ by inhibition of undifferentiated glioblastoma cells.

Yamamuro S, Sano E, Okamoto Y, Ochiai Y, Ohta T, Ogino A, Natsume A, Wakabayashi T, Ueda T, Hara H, Nakayama T, Yoshino A, Katayama Y.

Int J Oncol. 2015 Nov;47(5):1647-54. doi: 10.3892/ijo.2015.3165. Epub 2015 Sep 14.

44.

Applicable advances in the molecular pathology of glioblastoma.

Ranjit M, Motomura K, Ohka F, Wakabayashi T, Natsume A.

Brain Tumor Pathol. 2015 Jul;32(3):153-62. doi: 10.1007/s10014-015-0224-6. Epub 2015 Jun 16. Review.

PMID:
26078107
45.

Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness.

Tanahashi K, Natsume A, Ohka F, Motomura K, Alim A, Tanaka I, Senga T, Harada I, Fukuyama R, Sumiyoshi N, Sekido Y, Wakabayashi T.

J Neuropathol Exp Neurol. 2015 Jul;74(7):704-9. doi: 10.1097/NEN.0000000000000211.

PMID:
26049897
46.

Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor ╬▒ and Yes Kinase.

Ohkawa Y, Momota H, Kato A, Hashimoto N, Tsuda Y, Kotani N, Honke K, Suzumura A, Furukawa K, Ohmi Y, Natsume A, Wakabayashi T, Furukawa K.

J Biol Chem. 2015 Jun 26;290(26):16043-58. doi: 10.1074/jbc.M114.635755. Epub 2015 May 4.

47.

Mutational landscape and clonal architecture in grade II and III gliomas.

Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F, Yamamoto T, Tanahashi K, Ranjit M, Wakabayashi T, Yoshizato T, Kataoka K, Yoshida K, Nagata Y, Sato-Otsubo A, Tanaka H, Sanada M, Kondo Y, Nakamura H, Mizoguchi M, Abe T, Muragaki Y, Watanabe R, Ito I, Miyano S, Natsume A, Ogawa S.

Nat Genet. 2015 May;47(5):458-68. doi: 10.1038/ng.3273. Epub 2015 Apr 13.

PMID:
25848751
48.

Paired related homeobox 1 is associated with the invasive properties of glioblastoma cells.

Sugiyama M, Hasegawa H, Ito S, Sugiyama K, Maeda M, Aoki K, Wakabayashi T, Hamaguchi M, Natsume A, Senga T.

Oncol Rep. 2015 Mar;33(3):1123-30. doi: 10.3892/or.2014.3681. Epub 2014 Dec 18.

PMID:
25522823
49.

Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report.

Kuramitsu S, Motomura K, Natsume A, Wakabayashi T.

NMC Case Rep J. 2014 Oct 8;2(1):40-45. doi: 10.2176/nmccrj.2014-0025. eCollection 2015 Jan.

50.

Assessment of tumor cells in a mouse model of diffuse infiltrative glioma by Raman spectroscopy.

Tanahashi K, Natsume A, Ohka F, Momota H, Kato A, Motomura K, Watabe N, Muraishi S, Nakahara H, Saito Y, Takeuchi I, Wakabayashi T.

Biomed Res Int. 2014;2014:860241. doi: 10.1155/2014/860241. Epub 2014 Aug 27.

Supplemental Content

Loading ...
Support Center